Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I
暂无分享,去创建一个
Michael Roden | Barbara Brunmair | M. Roden | W. Waldhäusl | Andrea Lest | Katrin Staniek | Florian Gras | Nicole Scharf | Hans Nohl | Werner Waldhäusl | Clemens Fürnsinn | C. Fürnsinn | H. Nohl | K. Staniek | B. Brunmair | F. Gras | Nicole Scharf | Andrea Lest
[1] Allen Shek,et al. Statin—Fibrate Combination Therapy , 2001, The Annals of pharmacotherapy.
[2] K. Wallace,et al. The effect of peroxisome proliferators on mitochondrial bioenergetics. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.
[3] M. Kobayashi,et al. Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study , 1988, Diabetes Care.
[4] M. Prentki,et al. Insulin resistance in soleus muscle from obese Zucker rats. Involvement of several defective sites. , 1980, The Biochemical journal.
[5] M. Roden,et al. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? , 2004, Diabetes.
[6] Peter Olson,et al. Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0288 Minireview: Lipid Metabolism, Metabolic Diseases, and , 2022 .
[7] Christian Hodel,et al. Myopathy and rhabdomyolysis with lipid-lowering drugs. , 2002, Toxicology letters.
[8] M. Owen,et al. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. , 2000, The Biochemical journal.
[9] J Auwerx,et al. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. , 1996, Journal of lipid research.
[10] A. Garber,et al. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. , 2002, Biochemical and biophysical research communications.
[11] H Yamanaka,et al. Inhibition of mitochondrial respiration and oxygen-dependent hepatotoxicity by six structurally dissimilar peroxisomal proliferating agents. , 1992, Toxicology.
[12] M. Rigoulet,et al. Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I* , 2000, The Journal of Biological Chemistry.
[13] Bruno Derudas,et al. Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity* , 2000, The Journal of Biological Chemistry.
[14] D. McTavish,et al. Fenofibrate , 1990, Drugs.
[15] D. Rader,et al. Role of fibrates in the management of hypertriglyceridemia. , 1999, The American journal of cardiology.
[16] W. Waldhäusl,et al. Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle. , 1995, Diabetologia.
[17] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[18] A. Stalenhoef,et al. The Metabolic Syndrome: Targeting Dyslipidaemia to Reduce Coronary Risk , 2003, Journal of cardiovascular risk.
[19] B. Halliwell,et al. Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. , 2001, Free radical biology & medicine.
[20] S. Dimauro,et al. Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.
[21] A Ward,et al. Pentoxifylline , 1987, Drugs.
[22] J. Spence,et al. Clinical Pharmacokinetics of Fibric Acid Derivatives (Fibrates) , 1998, Clinical pharmacokinetics.
[23] L. Madsen,et al. PPARa activators improve insulin sensitivity and reduce adiposity , 2000 .
[24] M. Roden,et al. Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression. , 2001, Diabetes.